However, the individuals with both miR34b/c rs4938723 TC genotype and TP53 rs1042522 CC genotype might have a borderline significantly decreased risk of Wilms tumor (adjusted OR = 0.51, 95% CI = 0.25–1.01, P=0.053). This evidence concerns the gene TP53 and Nephroblastoma.